OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Tom MacGillivray

1 Projects | 1 Researchers | $488,997 Invested

2019

The University of Edinburgh

Tom MacGillivray, BSc, MSc, PhD

Delivering novel neuro-retinal biomarkers for the early diagnosis of Alzheimer’s disease

  • Funding Amount: $488,997
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Other
  • Status: Closed